87
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Post-transplantation Lymphoproliferative Disease in Chinese: The Queen Mary Hospital Experience in Hong Kong

, , , , , , , , , , , , & show all
Pages 1403-1407 | Published online: 01 Jul 2009

  • Monlone, K.T., Litzky, L.A., Wurster, A., Kaiser, I., Bavaria, J., Kotloff, R., et al., (1996) "Analysis of Epstein-Barr virus-associated post transplantation lymphoproliferative disorder after lung transplantation". Surgery 119(5), 544-551.
  • Swerdlow, S. (1997) "Classification of the post transplant lymphoproliferative disorders: from the past to the present". Semin. Diagn. Palhol. 14 (1), 2-7.
  • Domingo-Domenech, E., de Sanjose, S., Gonzalez-Barca, E., Romagosa, V. Domingo-Claros, A., Gil-Vemet, S., et al., (2001) "Post-transplant lymphomas: a 20 year epidemiologic, clinical and pathologic study in a single center". Haematologica 86(7), 715-721.
  • Kaplan, M., Ferry, J., Harris, N. and Jacobson, J. (1994) "Post transplant lymphoproliferative disorders: episomal BV is a more reliable marker of clonality than immunoglobulin gene rearrangement". Am. J. Clin. Pathol. 101, 590-596.
  • Harris, N.L., Jaffe, E.S., Deibold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., et al., (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlic House, Virginia. November 1997". J. Clin. Oncol. 17(12), 3835-3849.
  • Harris, N.L., Ferry, J.A. and Swerdlow, S.H. (1997) "Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop". Semin. Diagn. Pathol. 14(1), 8-14.
  • Knowles, D., Cesarman, E., Chadburn, A., et al., (1995) "Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post transplantation lymphoproliferative disorders", Blood 85, 522-565.
  • Nelson, B.P., Locker, J., Nalesnik, M.A., Fung, J.J. and Swerdlow, S.H. (1998) "Clonal and morphological variation in a post transplant lymphoproliferative disorder evolution from clonal T-cell to clonal B-cell predominance". Hum. Pathol. 29(4). 416-421.
  • Nalesnik, M.A. and Starzl, T.E. (1994) "Epstein-Barr virus, infectious mononucleosis, and post transplant lymphoproliferative disorders". Transplant Sd. 4(1), 61-79.
  • Purighalla, R., Shapiro, R., Jordan, M.L., Scantlebury, V.R., Gritsch, H.A., Vivas, C., et al., (1997) "Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder", Clin. Transplant 11(6), 574-576.
  • Manez, R., Breinig, M.K., Linden, P. Kusne, S., Torre-Cisneros, J., Wilson, J., et al., (1994) "Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients". Transplant Int. 7(Suppl 1), S235-S237.
  • Chiang, A.K., Tao, Q., Srivastava, G. and Ho. F.C. (1996) "Nasal N.K- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease". Int. J. Cancer 68(3), 285-290.
  • Kwong, Y.L., Lam, C.C. and Chan, T.M. (2000) "Posttransplantalion lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis". Br. J. Haematol 110(1), 197-202.
  • Hawkins, B.R., Chan, P., Chan, Y.T., Cheng. I.K., Cheung, K.O., Fenn, J., et al., (1997) "Highly successful long-term outcome of kidney transplantation in Chinese recipient: an enhancing race effect?", Clin. Transplant 11(3), 178-184.
  • Au, W.Y. Lie, A.K., Lee, C.K., Ma, S.K., Wan. T.S., Liang, R., et al., (2001) "Late onset, recipient derived post-transplantation lytnphoproliferative disease (PTLD) following cytogenetic leukemia relapse after allogeneic bone marrow transplantation (BMT)", Bone Marrow Transplant. 28(1), 417-419.
  • Ng, I.O., Shek, T.W., Thung, S.N., Ye, M.M., Lo, C.M., Fan, S.T., et al., (2000) "Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin", Mod. Pathol. 13(11), 1180-1185.
  • Au, W.Y. Lie, A.K., Ma, S.K., Leung, Y.H., Siu, L.I., and Kwong, Y.L. (2001) "Therapy-related myelodysplastic syndrome of recipient origin after allogeneic bone marrow transplantation for acute lymphoblastic leukaemia", Br. J. Haematol. 112(2), 424-426.
  • Lo, C.M., Fan, ST., Liu. C.L., Lai, C.L., Lau, G.K., Yong, B.H., et al., (2000) "Liver transplantation in Hong Kong -- a wider application". Transplant Proc. 32(7), 2141.
  • Swinnen, L.J. (2000) "Diagnosis and treatment of transplant-related lymphoma". Ann. Oncol. 11(Suppl 1), 45-48.
  • Socie, G., Curtis, R.E., Deeg, H.J., Sobocinski, K.A., Filipovich, A.H., Travis, L.B., et al., (2000) "New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia", J. Clin. Oncol. 18(2), 348-357.
  • Curtis, R.E., Travis, L.B., Rowlings, P.A., Socie, G., Kingma, D.W., Banks, P.M., et al., (1999) "Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study", Blood 94(7), 2208-2216.
  • Micallef, I.N., Chhanabhai, M., Gascoyne, R.D., Shepherd. J.D., Fung, H.C., Nantel, S.H., el al., (1998) "Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience", Bone Marrow Transplant. 22 (10), 981-987.
  • McCarthy, M., Ramage, J., McNair, A., Gane, E., Portmann, B., Pagliuca, A., et al., (1997) "The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients", J. Hepatol. 27(6), 1015-1021.
  • Leblond, V., Sutton. L., Dorent, R., Davi. F. Bitker, M.O., Gabarre. J., et al., (1995) "Lymphoproliferative disorders after organ transplaniation: a report of 24 cases observed in a single center". J. Clin. Oncol. 13(4), 961-968.
  • Morrison, V.A., Dunn. D.L., Manivel, J.C., Gajl Peczalska, K.J. and Peterson, B.A. (1994) "Clinical characteristics of post-transplant lymphoproliferative disorders". Am. J. Med. 97(1), 14-24.
  • Collins, M.H., Montons, K.T., Leahey, A.M., Hodinka, R.L., Salhany, K.E., Kramer. D.L., et al., (2001) "Post-transplant lymphoproliferative disease in children". Pediatr. Transplant. 5(4), 250-257.
  • Nagasawa, M., Hirai, K., Mizutani, S., Okawa, H. and Yata, J. (1999) "EBV infection induced transformation of benign T lymphoproliferative state in patient with chronic active EBV infection into malignant lymphoma: implication of EBV infection as additive oncogenic factor in tumorigenesis", Leak. Res. 23(11), 1071-1078.
  • Wong, J.Y., Tait, B., Levvey, B., Griffiths, A., Esmore, D.S., Snell, G.I., et al., (2001) "EBV mismatching and HLA matching post lung transplantation: key risk factors for post transplant lymphoproliferative disease(PTLD)". J. Heart Lung Transplant. 22(2), 199.
  • Shpilberg, O., Wilson, J., Whiteside, T.L. and Herberman, R.B. (1999) "Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group". Leuk. Lymph. 36(1-2). 109-121.
  • Harwood, J.S., Gould, F.K., McMaster, A., Hamilton, J.R., Corris. P.A., Hasan, A., et al. (1999) "Significance of Epstem-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation", Pediatr. Transplant. 3(2), 100-103.
  • Hsi, E.D., Picken, M.M. and Alkan, S. (1998) "Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature", Mod. Pathol. 11(5). 479-484.
  • Rees, L., Thomas, A. and Amlot, P.L. (1998) "Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosupptession". Lancet 352(9130), 789.
  • Shustik, C., Jamison, B.M., Alfieri, C., Scherer, S. and Loertscher, R. (1995) "A solitary plasmacytoma of donor origin arising 14 years after kidney allotransplamation", Br. J. Haematol. 91(1), 167-168.
  • Patchell, R.A. (1988) "Primary central nervous system lymphoma in the transplant patient". Neurol. Clin. 6(2), 297-303.
  • Hauke, R., Smir, B., Greiner, T., Bierman, P., Tarantolo, S., Anderson, J., et al., (2001) "Clinical and pathological features of post transplant lymphoproliferative disorders: influence on survival and response to treatment", Ann. Onecol. 12(6), 831-834.
  • Gross, T.G., Hinrichs, S.H., Winner. J., Greiner, T.C., Kaufman, S.S., Sammut, P.H., et al., (1998) "Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy", Ann. Oncol. 9(3), 339-340.
  • Schaar, C.G., vau der Piji, J.W., van Hoek, B., de Fijter, J.W., Veenendaal, R.A., Kluin. P.M., et al., (2001) "Successful outcome with a quintuple approach of post transplant lymphoproliferative disorder", Transplantation 71(1). 47-52.
  • Rooney, C.M., Smith, C.A., Ng, C.Y., Loftin, S.K., Sixbey, J.W., Gan, Y., et al., (1998) "Infusion of cytotoxic T cells tor the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients". Blood 92(5), 1549-1555.
  • Faye, A., Van Den Abeele, T., Peuchmaur, M., Mathieu Boue, A. and Vilmer, E. (1998) "Anti-CD20 monoclonal antibody for post-transplant lymphorpliferative disorders". Lancet 352(9136), 1285.
  • Lei, K.I., Chan. L.Y., Chan, W.Y., Johnson, P.J. and Lo, Y.M. (2000) "Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies", Br. J. Haematol. 111(1), 239-246.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.